Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 1;31(11):3119-3120.
doi: 10.1016/j.ymthe.2023.10.014. Epub 2023 Oct 20.

Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responses

David M Markusic  1 , Moanaro Biswas  2
Affiliations
Comment

Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responses

David M Markusic et al. Mol Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Comment on

  • Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
    Tremain AC, Wallace RP, Lorentz KM, Thornley TB, Antane JT, Raczy MR, Reda JW, Alpar AT, Slezak AJ, Watkins EA, Maulloo CD, Budina E, Solanki A, Nguyen M, Bischoff DJ, Harrington JL, Mishra R, Conley GP, Marlin R, Dereuddre-Bosquet N, Gallouët AS, LeGrand R, Wilson DS, Kontos S, Hubbell JA. Tremain AC, et al. Nat Biomed Eng. 2023 Sep;7(9):1142-1155. doi: 10.1038/s41551-023-01086-2. Epub 2023 Sep 7. Nat Biomed Eng. 2023. PMID: 37679570

References

    1. Thomson A.W., Knolle P.A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 2010;10:753–766. doi: 10.1038/nri2858. PubMed PMID: 20972472. - DOI - PubMed
    1. Horst A.K., Neumann K., Diehl L., Tiegs G. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell. Mol. Immunol. 2016;13:277–292. doi: 10.1038/cmi.2015.112. - DOI - PMC - PubMed
    1. Tremain A.C., Wallace R.P., Lorentz K.M., Thornley T.B., Antane J.T., Raczy M.R., Reda J.W., Alpar A.T., Slezak A.J., Watkins E.A., et al. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses. Nat. Biomed. Eng. 2023;7:1142–1155. doi: 10.1038/s41551-023-01086-2. - DOI - PubMed
    1. Krienke C., Kolb L., Diken E., Streuber M., Kirchhoff S., Bukur T., Akilli-Öztürk Ö., Kranz L.M., Berger H., Petschenka J., et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science. 2021;371:145–153. doi: 10.1126/science.aay3638. - DOI - PubMed
    1. Keeler G.D., Kumar S., Palaschak B., Silverberg E.L., Markusic D.M., Jones N.T., Hoffman B.E. Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis. Mol. Ther. 2018;26:173–183. doi: 10.1016/j.ymthe.2017.09.001. - DOI - PMC - PubMed

LinkOut - more resources